Metraipolis › archive › dc_440bc9ead3a0
Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report — Europe PMC PMID:41523718
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41523718
- DOI
- 10.7759/cureus.101082
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:31:08.206Z
- SHA-256 of the archived text
2bf3ac942f93b0e95dbc8a846e81db611f1619144551fc6dd6375b064e623281- Stable URL of this page
https://metraipolis.com/documento/dc_440bc9ead3a0
How to cite
Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report — Europe PMC PMID:41523718 — Europe PMC (en), https://europepmc.org/article/MED/41523718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_440bc9ead3a0 (Metraipolis archive dc_440bc9ead3a0, sha256 2bf3ac942f93b0e95dbc8a846e81db611f1619144551fc6dd6375b064e623281)
BibTeX
@misc{dc440bc9ead3a0,
title = {Pembrolizumab-Induced Colitis With Concurrent Capecitabine in Triple-Negative Breast Carcinoma: A Case Report — Europe PMC PMID:41523718},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41523718},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_440bc9ead3a0; sha256 2bf3ac942f93b0e95dbc8a846e81db611f1619144551fc6dd6375b064e623281},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41523718. Agents can read the archived copy with the MCP tool read_document.